[logo] HealthTree Foundation
search person

How Is Peripheral T-Cell Lymphoma Staged And Classified?

Peripheral T-Cell Lymphoma (PTCL) is staged using the Ann Arbor staging system, which is commonly used for all types of lymphomas. This system takes into account the number of lymph node regions involved, whether the affected lymph nodes are on one or both sides of the diaphragm, and whether the disease has spread to organs outside of the lymphatic system.

The stages are as follows:

  • Stage I: The cancer is in a single lymph node region or a single organ outside the lymphatic system.
  • Stage II: The cancer is in two or more lymph node regions on the same side of the diaphragm, or the cancer has extended from a single lymph node region into a nearby organ.
  • Stage III: The cancer is in lymph node regions on both sides of the diaphragm.
  • Stage IV: The cancer has spread to several parts of one or more organs outside the lymphatic system.

Classification of Peripheral T-Cell Lymphoma

Peripheral T-Cell Lymphoma is classified based on the type of T-cells that the cancer starts in, the features of the cancer cells, and where the cancer develops in the body. The World Health Organization (WHO) has identified several subtypes of PTCL, including:

  • Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)
  • Anaplastic large cell lymphoma (ALCL), ALK-positive
  • Anaplastic large cell lymphoma (ALCL), ALK-negative
  • Angioimmunoblastic T-cell lymphoma (AITL)
  • Enteropathy-associated T-cell lymphoma (EATL)

What are the Phases of Peripheral T-Cell Lymphoma?

The phases of Peripheral T-Cell Lymphoma typically follow the stages of the disease. After diagnosis and staging, the disease enters the treatment phase, which may involve chemotherapy, radiation therapy, stem cell transplant, or other therapies. This is followed by the post-treatment phase, where patients are closely monitored for signs of relapse. In the event of a relapse, the disease re-enters the treatment phase.

Want to Learn More About Peripheral T-Cell Lymphoma?

Keep reading HealthTree for Peripheral T-Cell Lymphoma's 101 pages!

Peripheral T-Cell Lymphoma (PTCL) is staged using the Ann Arbor staging system, which is commonly used for all types of lymphomas. This system takes into account the number of lymph node regions involved, whether the affected lymph nodes are on one or both sides of the diaphragm, and whether the disease has spread to organs outside of the lymphatic system.

The stages are as follows:

  • Stage I: The cancer is in a single lymph node region or a single organ outside the lymphatic system.
  • Stage II: The cancer is in two or more lymph node regions on the same side of the diaphragm, or the cancer has extended from a single lymph node region into a nearby organ.
  • Stage III: The cancer is in lymph node regions on both sides of the diaphragm.
  • Stage IV: The cancer has spread to several parts of one or more organs outside the lymphatic system.

Classification of Peripheral T-Cell Lymphoma

Peripheral T-Cell Lymphoma is classified based on the type of T-cells that the cancer starts in, the features of the cancer cells, and where the cancer develops in the body. The World Health Organization (WHO) has identified several subtypes of PTCL, including:

  • Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)
  • Anaplastic large cell lymphoma (ALCL), ALK-positive
  • Anaplastic large cell lymphoma (ALCL), ALK-negative
  • Angioimmunoblastic T-cell lymphoma (AITL)
  • Enteropathy-associated T-cell lymphoma (EATL)

What are the Phases of Peripheral T-Cell Lymphoma?

The phases of Peripheral T-Cell Lymphoma typically follow the stages of the disease. After diagnosis and staging, the disease enters the treatment phase, which may involve chemotherapy, radiation therapy, stem cell transplant, or other therapies. This is followed by the post-treatment phase, where patients are closely monitored for signs of relapse. In the event of a relapse, the disease re-enters the treatment phase.

Want to Learn More About Peripheral T-Cell Lymphoma?

Keep reading HealthTree for Peripheral T-Cell Lymphoma's 101 pages!

newsletter icon

Get the latest thought leadership on your Peripheral T-Cell Lymphoma delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Peripheral T-Cell Lymphoma Sponsors:

Abbvie
Astellas Pharma
Servier